AR and pachyonychia congenita: Collectively, our results reveal that DHX9 participates in the control of the AR transcriptional program and suggest a novel molecular crosstalk between AR and DHX9 in the regulation of tumorigenic features of PC cells, which could represent a new promising therapeutic strategy for PC.